Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions

Baixue Lv, Dongdong Zhang Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, People’s Republic of ChinaCorrespondence: Dongdong Zhang, Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Jiefang Road...

Full description

Saved in:
Bibliographic Details
Main Authors: Lv B, Zhang D
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Biologics: Targets & Therapy
Subjects:
Online Access:https://www.dovepress.com/targeting-crebrf-in-cancer-mechanistic-insights-and-future-directions-peer-reviewed-fulltext-article-BTT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849417923090710528
author Lv B
Zhang D
author_facet Lv B
Zhang D
author_sort Lv B
collection DOAJ
description Baixue Lv, Dongdong Zhang Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, People’s Republic of ChinaCorrespondence: Dongdong Zhang, Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Jiefang Road No. 15, Xiangyang, Hubei, 441000, People’s Republic of China, Tel +8615072278600, Email zhangdongdong@whu.edu.cnAbstract: Luman/CREB3 recruitment factor (LRF), also known as CREBRF, was initially identified as a cellular binding protein of Luman through yeast two-hybrid screening of a human brain cDNA library. CREBRF plays a critical role in various biological processes, with its functions garnering significant attention in the field of oncology. Notably, CREBRF is involved in endoplasmic reticulum (ER) stress and regulates the unfolded protein response (UPR), leading to an accumulation of misfolded proteins. This can ultimately result in cellular dysfunction, apoptosis, and even tumorigenesis. In solid tumors, hypoxia is a common condition, and CREBRF has been implicated in hypoxia-induced autophagy, which promotes tumor cell proliferation. Depending on the tumor type and microenvironment, CREBRF exerts diverse effects by modulating distinct signaling pathways. This review summarizes CREBRF’s involvement in ER stress, cell cycle regulation, autophagy, and the mechanisms through which it influences tumor initiation and progression across various cancer types. Furthermore, the potential of CREBRF as a therapeutic target in cancer treatment is discussed, providing insights into future research and clinical applications.Keywords: CREBRF, ER, hypoxia, tumor, autophagy, therapeutic target
format Article
id doaj-art-80af6ed1d8384ebaa190882810ecef2f
institution Kabale University
issn 1177-5491
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Biologics: Targets & Therapy
spelling doaj-art-80af6ed1d8384ebaa190882810ecef2f2025-08-20T03:32:36ZengDove Medical PressBiologics: Targets & Therapy1177-54912025-05-01Volume 19Issue 1341350103432Targeting CREBRF in Cancer: Mechanistic Insights and Future DirectionsLv BZhang D0Department of OncologyBaixue Lv, Dongdong Zhang Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, People’s Republic of ChinaCorrespondence: Dongdong Zhang, Department of Oncology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Jiefang Road No. 15, Xiangyang, Hubei, 441000, People’s Republic of China, Tel +8615072278600, Email zhangdongdong@whu.edu.cnAbstract: Luman/CREB3 recruitment factor (LRF), also known as CREBRF, was initially identified as a cellular binding protein of Luman through yeast two-hybrid screening of a human brain cDNA library. CREBRF plays a critical role in various biological processes, with its functions garnering significant attention in the field of oncology. Notably, CREBRF is involved in endoplasmic reticulum (ER) stress and regulates the unfolded protein response (UPR), leading to an accumulation of misfolded proteins. This can ultimately result in cellular dysfunction, apoptosis, and even tumorigenesis. In solid tumors, hypoxia is a common condition, and CREBRF has been implicated in hypoxia-induced autophagy, which promotes tumor cell proliferation. Depending on the tumor type and microenvironment, CREBRF exerts diverse effects by modulating distinct signaling pathways. This review summarizes CREBRF’s involvement in ER stress, cell cycle regulation, autophagy, and the mechanisms through which it influences tumor initiation and progression across various cancer types. Furthermore, the potential of CREBRF as a therapeutic target in cancer treatment is discussed, providing insights into future research and clinical applications.Keywords: CREBRF, ER, hypoxia, tumor, autophagy, therapeutic targethttps://www.dovepress.com/targeting-crebrf-in-cancer-mechanistic-insights-and-future-directions-peer-reviewed-fulltext-article-BTTCREBRFERhypoxiatumorautophagytherapeutic target.
spellingShingle Lv B
Zhang D
Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
Biologics: Targets & Therapy
CREBRF
ER
hypoxia
tumor
autophagy
therapeutic target.
title Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
title_full Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
title_fullStr Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
title_full_unstemmed Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
title_short Targeting CREBRF in Cancer: Mechanistic Insights and Future Directions
title_sort targeting crebrf in cancer mechanistic insights and future directions
topic CREBRF
ER
hypoxia
tumor
autophagy
therapeutic target.
url https://www.dovepress.com/targeting-crebrf-in-cancer-mechanistic-insights-and-future-directions-peer-reviewed-fulltext-article-BTT
work_keys_str_mv AT lvb targetingcrebrfincancermechanisticinsightsandfuturedirections
AT zhangd targetingcrebrfincancermechanisticinsightsandfuturedirections